Table 2.
Model Parameter | Parent SCARED | Parent MASC | Child MASC | Parent CSR | Child CSR |
---|---|---|---|---|---|
Initial phase slope (SE) | −.675 (.232)** | −.480 (.200)* | −.340 (.332) | −.431 (.164)** | −.082 (.142) |
Mid-point intercept (SE)a | −.298 (.129)* | −.276 (.126)* | −.047 (.152) | −.363 (.138)** | −.052 (.122) |
2nd phase slope (SE) | .214 (.214) | .050 (.198) | .016 (.269) | .393 (.383) | −.045 (.202) |
Note: SE = standard error. Group was coded as 1 = treatment and 0 = control.
Mid-point intercept was set at 3-month posttreatment for parent SCARED, parent and child MASC, and at 1-year posttreatment for parent and child CSR.
p < .05,
p < .01.